BREONICS, INC.
Nano-barrier membrane (NB-LVF4) made of laminin, vitrogen, fibronectin, and type IV collagen that immunocloaks renal allograft vascular surfaces to prevent rejection
- Sector
- Medtech
- Total capital
- $2.2M
- Federal grants
- $2.2M
- 3 awards · 2015–2016
- Rank in peer group#35 of 36
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 4 pending
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · The Potential to Immunocloak Renal Allografts$961K
- Federal grantHealth and Human S · Phase I · Cell therapy for Repairing Warm Ischemically Damaged Kidneys$300K
- Federal grantHealth and Human S · Phase II · The Potential to Immunocloak Renal Allografts$961K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 36 peers
Line = medianMedtech · Material
- Federal grantsBelow median
- Linked publications#1 · top 3%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 4- PendingMethods And Compositions To Modify The Immunogenicity Of A Vascularized Organ Or TissueUSPTOApplication 61722507
- PendingOrgan Chamber For Ex Vivo Warm PerfusionUSPTOApplication PCTUS2012052528
- PendingSystem For Exsanguinous Metabolic Support Of An Organ Or TissueUSPTOApplication PCTUS2004016085
Show all 4 patent records
- Methods And Compositions To Modify The Immunogenicity Of A Vascularized Organ Or TissueApplication 61722507Pending
- Organ Chamber For Ex Vivo Warm PerfusionApplication PCTUS2012052528Pending
- System For Exsanguinous Metabolic Support Of An Organ Or TissueApplication PCTUS2004016085Pending
- Organ Chamber For Exsanguinous Metabolic Support SystemApplication PCTUS2001040679Pending
Recent research by its founders
- Contributors20210 cites
- Repairing organs with MSC20210 cites
- Will cell therapies provide the solution for the shortage of transplantable organs?20197 cites
Related companies, and why
- Integral Biosystems, LLCSimilar federal contract value in Medtech · null in contracts
- COHERE-MED, INC.Similar federal contract value in Medtech · null in contracts
- Purist IncSimilar federal contract value in Medtech · null in contracts
- ELGAVISH PARAMAGNETICS, INC.Similar federal contract value in Medtech · null in contracts
- Happy Tunes Productions, LLCSimilar federal contract value in Medtech · null in contracts
- HEPATOSYS INCSimilar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .